ZOOL SCI 润色咨询

ZOOLOGICAL SCIENCE

出版年份：1984 年文章数：2940 投稿命中率： 开通期刊会员，数据随心看

出版周期：Monthly 自引率：2.8% 审稿周期： 开通期刊会员，数据随心看

前往期刊查询
期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=1098876, encodeId=736410988e683, content=如果文章发表了未提供ORCIDID如何添加？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1098875, encodeId=a37710988e5dd, content=如何判断两种药物之间是协同作用还是相加作用？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=543069, encodeId=0f5454306987, content=反正就这个熊样,也不会有所变化,只要不跌,也就万幸了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=256, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=weiwei_zhu, createdTime=Fri Jul 14 18:51:00 CST 2017, time=2017-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=503679, encodeId=17ee5036e979, content=很好的一个杂志，太别严谨，发表文章让人有一种成就感。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=264, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Fri Jun 20 18:00:00 CST 2014, time=2014-06-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=829169, encodeId=c71882916933, content=貌似对格式要求很严格啊 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8ec15413992, createdName=ms9495958415321966, createdTime=Sat Nov 09 10:21:00 CST 2013, time=2013-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=486728, encodeId=f8f5486e2831, content=选择这个杂志是很有挑战性的。能够让人学会真正的科学严谨性！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=308, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=448e33316, createdName=yangyang518, createdTime=Thu Feb 16 11:04:00 CST 2012, time=2012-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=486727, encodeId=168d486e27ce, content=审稿速度:3.0 | 投稿命中率:25.0<br>经验分享：2012 Impact Factor: 1.087 <br> <br> , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=385, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=448e33316, createdName=yangyang518, createdTime=Thu Feb 16 11:02:00 CST 2012, time=2012-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=486467, encodeId=9c6e48646ef1, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享：很严谨的一个杂志！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=300, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Tue Jan 31 22:32:00 CST 2012, time=2012-01-31, status=1, ipAttribution=)]
    2021-12-28 乌云背后的幸福线

    如果文章发表了未提供ORCIDID如何添加？

    1

    展开1条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=1098876, encodeId=736410988e683, content=如果文章发表了未提供ORCIDID如何添加？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1098875, encodeId=a37710988e5dd, content=如何判断两种药物之间是协同作用还是相加作用？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=543069, encodeId=0f5454306987, content=反正就这个熊样,也不会有所变化,只要不跌,也就万幸了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=256, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=weiwei_zhu, createdTime=Fri Jul 14 18:51:00 CST 2017, time=2017-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=503679, encodeId=17ee5036e979, content=很好的一个杂志，太别严谨，发表文章让人有一种成就感。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=264, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Fri Jun 20 18:00:00 CST 2014, time=2014-06-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=829169, encodeId=c71882916933, content=貌似对格式要求很严格啊 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8ec15413992, createdName=ms9495958415321966, createdTime=Sat Nov 09 10:21:00 CST 2013, time=2013-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=486728, encodeId=f8f5486e2831, content=选择这个杂志是很有挑战性的。能够让人学会真正的科学严谨性！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=308, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=448e33316, createdName=yangyang518, createdTime=Thu Feb 16 11:04:00 CST 2012, time=2012-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=486727, encodeId=168d486e27ce, content=审稿速度:3.0 | 投稿命中率:25.0<br>经验分享：2012 Impact Factor: 1.087 <br> <br> , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=385, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=448e33316, createdName=yangyang518, createdTime=Thu Feb 16 11:02:00 CST 2012, time=2012-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=486467, encodeId=9c6e48646ef1, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享：很严谨的一个杂志！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=300, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Tue Jan 31 22:32:00 CST 2012, time=2012-01-31, status=1, ipAttribution=)]
    2021-12-27 学医的彭于晏

    如何判断两种药物之间是协同作用还是相加作用？

    1

    展开1条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=1098876, encodeId=736410988e683, content=如果文章发表了未提供ORCIDID如何添加？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1098875, encodeId=a37710988e5dd, content=如何判断两种药物之间是协同作用还是相加作用？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=543069, encodeId=0f5454306987, content=反正就这个熊样,也不会有所变化,只要不跌,也就万幸了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=256, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=weiwei_zhu, createdTime=Fri Jul 14 18:51:00 CST 2017, time=2017-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=503679, encodeId=17ee5036e979, content=很好的一个杂志，太别严谨，发表文章让人有一种成就感。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=264, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Fri Jun 20 18:00:00 CST 2014, time=2014-06-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=829169, encodeId=c71882916933, content=貌似对格式要求很严格啊 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8ec15413992, createdName=ms9495958415321966, createdTime=Sat Nov 09 10:21:00 CST 2013, time=2013-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=486728, encodeId=f8f5486e2831, content=选择这个杂志是很有挑战性的。能够让人学会真正的科学严谨性！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=308, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=448e33316, createdName=yangyang518, createdTime=Thu Feb 16 11:04:00 CST 2012, time=2012-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=486727, encodeId=168d486e27ce, content=审稿速度:3.0 | 投稿命中率:25.0<br>经验分享：2012 Impact Factor: 1.087 <br> <br> , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=385, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=448e33316, createdName=yangyang518, createdTime=Thu Feb 16 11:02:00 CST 2012, time=2012-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=486467, encodeId=9c6e48646ef1, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享：很严谨的一个杂志！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=300, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Tue Jan 31 22:32:00 CST 2012, time=2012-01-31, status=1, ipAttribution=)]
    2017-07-14 weiwei_zhu

    反正就这个熊样,也不会有所变化,只要不跌,也就万幸了

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1098876, encodeId=736410988e683, content=如果文章发表了未提供ORCIDID如何添加？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1098875, encodeId=a37710988e5dd, content=如何判断两种药物之间是协同作用还是相加作用？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=543069, encodeId=0f5454306987, content=反正就这个熊样,也不会有所变化,只要不跌,也就万幸了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=256, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=weiwei_zhu, createdTime=Fri Jul 14 18:51:00 CST 2017, time=2017-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=503679, encodeId=17ee5036e979, content=很好的一个杂志，太别严谨，发表文章让人有一种成就感。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=264, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Fri Jun 20 18:00:00 CST 2014, time=2014-06-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=829169, encodeId=c71882916933, content=貌似对格式要求很严格啊 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8ec15413992, createdName=ms9495958415321966, createdTime=Sat Nov 09 10:21:00 CST 2013, time=2013-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=486728, encodeId=f8f5486e2831, content=选择这个杂志是很有挑战性的。能够让人学会真正的科学严谨性！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=308, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=448e33316, createdName=yangyang518, createdTime=Thu Feb 16 11:04:00 CST 2012, time=2012-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=486727, encodeId=168d486e27ce, content=审稿速度:3.0 | 投稿命中率:25.0<br>经验分享：2012 Impact Factor: 1.087 <br> <br> , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=385, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=448e33316, createdName=yangyang518, createdTime=Thu Feb 16 11:02:00 CST 2012, time=2012-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=486467, encodeId=9c6e48646ef1, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享：很严谨的一个杂志！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=300, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Tue Jan 31 22:32:00 CST 2012, time=2012-01-31, status=1, ipAttribution=)]
    2014-06-20 匿名用户

    很好的一个杂志，太别严谨，发表文章让人有一种成就感。

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1098876, encodeId=736410988e683, content=如果文章发表了未提供ORCIDID如何添加？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1098875, encodeId=a37710988e5dd, content=如何判断两种药物之间是协同作用还是相加作用？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=543069, encodeId=0f5454306987, content=反正就这个熊样,也不会有所变化,只要不跌,也就万幸了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=256, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=weiwei_zhu, createdTime=Fri Jul 14 18:51:00 CST 2017, time=2017-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=503679, encodeId=17ee5036e979, content=很好的一个杂志，太别严谨，发表文章让人有一种成就感。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=264, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Fri Jun 20 18:00:00 CST 2014, time=2014-06-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=829169, encodeId=c71882916933, content=貌似对格式要求很严格啊 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8ec15413992, createdName=ms9495958415321966, createdTime=Sat Nov 09 10:21:00 CST 2013, time=2013-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=486728, encodeId=f8f5486e2831, content=选择这个杂志是很有挑战性的。能够让人学会真正的科学严谨性！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=308, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=448e33316, createdName=yangyang518, createdTime=Thu Feb 16 11:04:00 CST 2012, time=2012-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=486727, encodeId=168d486e27ce, content=审稿速度:3.0 | 投稿命中率:25.0<br>经验分享：2012 Impact Factor: 1.087 <br> <br> , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=385, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=448e33316, createdName=yangyang518, createdTime=Thu Feb 16 11:02:00 CST 2012, time=2012-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=486467, encodeId=9c6e48646ef1, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享：很严谨的一个杂志！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=300, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Tue Jan 31 22:32:00 CST 2012, time=2012-01-31, status=1, ipAttribution=)]
    2013-11-09 ms9495958415321966

    貌似对格式要求很严格啊

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1098876, encodeId=736410988e683, content=如果文章发表了未提供ORCIDID如何添加？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1098875, encodeId=a37710988e5dd, content=如何判断两种药物之间是协同作用还是相加作用？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=543069, encodeId=0f5454306987, content=反正就这个熊样,也不会有所变化,只要不跌,也就万幸了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=256, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=weiwei_zhu, createdTime=Fri Jul 14 18:51:00 CST 2017, time=2017-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=503679, encodeId=17ee5036e979, content=很好的一个杂志，太别严谨，发表文章让人有一种成就感。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=264, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Fri Jun 20 18:00:00 CST 2014, time=2014-06-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=829169, encodeId=c71882916933, content=貌似对格式要求很严格啊 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8ec15413992, createdName=ms9495958415321966, createdTime=Sat Nov 09 10:21:00 CST 2013, time=2013-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=486728, encodeId=f8f5486e2831, content=选择这个杂志是很有挑战性的。能够让人学会真正的科学严谨性！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=308, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=448e33316, createdName=yangyang518, createdTime=Thu Feb 16 11:04:00 CST 2012, time=2012-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=486727, encodeId=168d486e27ce, content=审稿速度:3.0 | 投稿命中率:25.0<br>经验分享：2012 Impact Factor: 1.087 <br> <br> , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=385, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=448e33316, createdName=yangyang518, createdTime=Thu Feb 16 11:02:00 CST 2012, time=2012-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=486467, encodeId=9c6e48646ef1, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享：很严谨的一个杂志！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=300, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Tue Jan 31 22:32:00 CST 2012, time=2012-01-31, status=1, ipAttribution=)]
    2012-02-16 yangyang518

    选择这个杂志是很有挑战性的。能够让人学会真正的科学严谨性！

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=1098876, encodeId=736410988e683, content=如果文章发表了未提供ORCIDID如何添加？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1098875, encodeId=a37710988e5dd, content=如何判断两种药物之间是协同作用还是相加作用？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=543069, encodeId=0f5454306987, content=反正就这个熊样,也不会有所变化,只要不跌,也就万幸了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=256, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=weiwei_zhu, createdTime=Fri Jul 14 18:51:00 CST 2017, time=2017-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=503679, encodeId=17ee5036e979, content=很好的一个杂志，太别严谨，发表文章让人有一种成就感。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=264, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Fri Jun 20 18:00:00 CST 2014, time=2014-06-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=829169, encodeId=c71882916933, content=貌似对格式要求很严格啊 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8ec15413992, createdName=ms9495958415321966, createdTime=Sat Nov 09 10:21:00 CST 2013, time=2013-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=486728, encodeId=f8f5486e2831, content=选择这个杂志是很有挑战性的。能够让人学会真正的科学严谨性！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=308, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=448e33316, createdName=yangyang518, createdTime=Thu Feb 16 11:04:00 CST 2012, time=2012-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=486727, encodeId=168d486e27ce, content=审稿速度:3.0 | 投稿命中率:25.0<br>经验分享：2012 Impact Factor: 1.087 <br> <br> , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=385, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=448e33316, createdName=yangyang518, createdTime=Thu Feb 16 11:02:00 CST 2012, time=2012-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=486467, encodeId=9c6e48646ef1, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享：很严谨的一个杂志！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=300, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Tue Jan 31 22:32:00 CST 2012, time=2012-01-31, status=1, ipAttribution=)]
    2012-02-16 yangyang518

    审稿速度:3.0 | 投稿命中率:25.0
    经验分享：2012 Impact Factor: 1.087

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=1098876, encodeId=736410988e683, content=如果文章发表了未提供ORCIDID如何添加？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1098875, encodeId=a37710988e5dd, content=如何判断两种药物之间是协同作用还是相加作用？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=543069, encodeId=0f5454306987, content=反正就这个熊样,也不会有所变化,只要不跌,也就万幸了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=256, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=weiwei_zhu, createdTime=Fri Jul 14 18:51:00 CST 2017, time=2017-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=503679, encodeId=17ee5036e979, content=很好的一个杂志，太别严谨，发表文章让人有一种成就感。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=264, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Fri Jun 20 18:00:00 CST 2014, time=2014-06-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=829169, encodeId=c71882916933, content=貌似对格式要求很严格啊 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8ec15413992, createdName=ms9495958415321966, createdTime=Sat Nov 09 10:21:00 CST 2013, time=2013-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=486728, encodeId=f8f5486e2831, content=选择这个杂志是很有挑战性的。能够让人学会真正的科学严谨性！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=308, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=448e33316, createdName=yangyang518, createdTime=Thu Feb 16 11:04:00 CST 2012, time=2012-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=486727, encodeId=168d486e27ce, content=审稿速度:3.0 | 投稿命中率:25.0<br>经验分享：2012 Impact Factor: 1.087 <br> <br> , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=385, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=448e33316, createdName=yangyang518, createdTime=Thu Feb 16 11:02:00 CST 2012, time=2012-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=486467, encodeId=9c6e48646ef1, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享：很严谨的一个杂志！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=300, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Tue Jan 31 22:32:00 CST 2012, time=2012-01-31, status=1, ipAttribution=)]
    2012-01-31 匿名用户

    审稿速度:3.0 | 投稿命中率:50.0
    经验分享：很严谨的一个杂志！

    0

共11条页码: 1/2页10条/页
分享您的投稿经验，提升MI经验值，获取更多积分